Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors
Introduction
Leukocytes infiltrate neoplastic tissues and are a manifestation of inflammation in the context of neoplastic disorders [1]. Mononuclear phagocytes are a major component of the leukocyte infiltrate of tumors [2]. Tumor-associated macrophages (TAM) have complex, dual functions in their interaction with neoplastic cells, but strong evidence suggests that they are part of inflammatory circuits that promote tumor progression.
Macrophage are versatile cells which respond and adapt to microenvironmental signals. Classic macrophage activation in response to microbial agents and cytokines, interferon-γ (IFNγ) in particular, has long been recognized [3]. More recently, it was realized that antiinflammatory molecules, such as glucocorticoid hormones, IL-4, IL-13 and IL-10, are more than simple inhibitors of macrophage activation, in that they induce a distinct activation program (alternatively activated macrophages) [4], [5], [6], [7]. In analogy with the Th1/Th2 dichotomy in T cell responses, macrophages exposed to IFNγ and IL-4 have also been referred to as M1 and M2 [8]. Available information suggests that classically activated type I macrophages (M1) are potent effector cells which kill microorganisms and tumor cells and produce copious amounts of proinflammatory cytokines. In contrast, type II macrophages (M2) tune inflammatory responses and adaptive Th1 immunity, scavenge debris, promote angiogenesis, tissue remodeling and repair. Recent information support the emerging view that TAM are a polarized type II (or M2 or alternatively activated) macrophage population [4], [5], [8]. The polarized functions of TAM integrate them in circuits of subversion of antitumor immunity and in inflammatory mechanisms which promote tumor growth and progression.
Chemokines play a key role in the recruitment and shaping of the leukocyte infiltrate of tumors. Historically, tumor cells have been invaluable for the discovery and characterization of components of the chemokine system. Here we will review how chemokines direct migration of leukocytes in neoplastic tissue and how they contribute to shaping the functional properties of infiltrating cells, with a focus on TAM and tumor-associated dendritic cells (DC).
Section snippets
Chemokines in polarized macrophage populations
Components of the chemokine network are differentially modulated in polarized macrophages. IL-10 up-regulates the CC chemokine receptors CCR1, CCR2 and CCR5. In contrast, CXCR2 and CXCR4 are partially down-regulated under the same conditions [9]. An increase of CCR2 expression is also observed in monocytes exposed to dexamethasone [10]. IL-4 and IL-13 do not modify the expression of CC chemokine receptors but induce functional CXCL8 (IL-8) receptors in human monocytes [11]. On the contrary,
Chemokines involved in macrophage infiltration
TAM derive from circulating monocytic precursors and in situ proliferation is generally not an important mechanism that sustains the mononuclear phagocyte population, at least in human tumors [20]. Several lines of evidence, including correlation between production and infiltration in murine and human tumors, passive immunization and gene modification, indicate that chemokines play a pivotal role in the recruitment of monocytes in neoplastic tissues [21]. Indeed, tumors have been invaluable for
Positioning of macrophages in hypoxic areas
Uneven vascularization and hypoxia are characteristics of neoplastic tissues which affect macrophage distribution and function. TAM accumulate preferentially in the poorly vascularized region of tumors which are characterized by low oxygen tension. Recent studies have shown that macrophage migration is suppressed in hypoxic condition [39], [40] and that TAM are immobilized in avascular [41] and necrotic hypoxic areas of tumors [42]. Evidence suggests that in hypoxia TAM are stimulated to
Chemokines and adaptive antitumor immunity
As mentioned above, chemokines are more than leukocyte attractants. Chemokine are part of amplification and regulation systems of polarized T cell responses. Work in gene-modified mice has shown that CCL2, produced by a variety of tumors, can orient specific immunity in a Th2 direction, although the exact mechanism for this action has not been defined [49]. It may include stimulation of IL-10 production in macrophages. In addition to being produced by neoplastic cells, CCL2 is also expressed at
References (66)
- et al.
Inflammation and cancer: back to Virchow?
Lancet
(2001) - et al.
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
Trends Immunol.
(2002) - et al.
Other functions, other genes: alternative activation of antigen-presenting cells
Immunity
(1999) - et al.
Divergent effects of IL-4 and interferon gamma on macrophage-derived chemokine (MDC) production: an amplification circuit of polarized T helper 2 responses
Blood
(1998) - et al.
The origin and function of tumor-associated macrophages
Immunol. Today
(1992) The chemokine system: redundancy for robust outputs
Immunol. Today
(1999)- et al.
A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells
J. Biol. Chem.
(2002) - et al.
Chemotactic factors, passive invasion and metastasis of cancer cells
Immunol. Today
(1992) - et al.
The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages
Am. J. Pathol.
(2000) - et al.
HIF-1alpha is essential for myeloid cell-mediated inflammation
Cell
(2003)
High expression of the CC chemokine TARC in Reed–Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin’s lymphoma
Am. J. Pathol.
Reed–Sternberg cell genome expression supports a B-cell lineage
Blood
Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/Pulmonary and activation-regulated chemokine in ovarian carcinoma
J. Biol. Chem.
Chemokines in cancer
Cytokine Growth Factor Rev.
Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cell to release chemokines active in recruiting dendritic cells
Am. J. Pathol.
Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes
Blood
Interleukin 4 potently enhances murine mannose receptor activity: a marker of alternative immunologic macrophage activation
J. Exp. Med.
Alternative activation of macrophages
Nat. Rev. Immunol.
The many faces of macrophage activation
J. Leukoc. Biol.
M-1/M-2 macrophages and the Th1/Th2 paradigm
J. Immunol.
Interleukin-10 increases CCR5 expression and HIV infection in human monocytes
J. Exp. Med.
Upregulation of CCR2 chemokine receptor expression and increased susceptibility to the multitropic HIV strain 89.6 in monocytes exposed to glucocorticoid hormones
J. Immunol.
Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes
J. Immunol.
Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes
J. Exp. Med.
Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-g
J. Immunol.
Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys
Nat. Immunol.
Eotaxin-2 generation is differentially regulated by lipopolysaccharide and IL-4 in monocytes and macrophages
J. Immunol.
Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern
J. Immunol.
Unique regulation of CCL18 production by maturing dendritic cells
J. Immunol.
Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells
Cancer Res.
Cited by (170)
Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy
2024, Asian Journal of Pharmaceutical SciencesRole of macrophages in cancer progression and targeted immunotherapies
2023, Advances in Protein Chemistry and Structural BiologyImmune cellular components and signaling pathways in the tumor microenvironment
2022, Seminars in Cancer BiologyCitation Excerpt :Furthermore, epigenetic targeting of MDSC in mice bearing immunotherapy-resistant tumors resulted in tumor eradication after anti-PD-1/anti-CTLA4 combined immunotherapy [87]. After egress from the bone marrow, monocytes (or M-MDSCs) are recruited to the TME via chemokines of the CC and CXC families, such as CCL2, CCL5, and CXCL12 [88] produced by cancer cells at early stages of the cancer immunity cycle and convert to bone marrow-derived tumor associated macrophages (Fig. 1), which, together with embryonically-derived tissue resident macrophages, form the population of TAMs. TAMs represent the most abundant immune population of the TME, consisting ~50% of hematopoietic cells and have predominantly pro-tumorigenic functions [89].